Recombinant NKG2A (Monalizumab Biosimilar) anticorps
Aperçu rapide pour Recombinant NKG2A (Monalizumab Biosimilar) anticorps (ABIN7597834)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Expression System
- Mammalian cells
-
Fonction
- Research Grade Monalizumab Biosimilar Antibody
-
Specificité
- KLRC1, NKG2-A/NKG2-B type II integral membrane protein, NKG2-A/B-activating NK receptor, CD159 antigen-like family member A, CD159a, NK cell receptor A, NKG2A
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Pureté
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 6.65 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Date de péremption
- 12 months
-
-
- NKG2A (Monalizumab Biosimilar)
-
Autre désignation
- Monalizumab Biosimilar
-
Classe de substances
- Biosimilar
-
Sujet
- KLRC1, NKG2-A/NKG2-B type II integral membrane protein, NKG2-A/B-activating NK receptor, CD159 antigen-like family member A, CD159a, NK cell receptor A, NKG2A
-
UniProt
- P26715
-
Numéro CAS
- 1228763-95-8
Antigène
-